These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 9950667
21. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate. Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J. Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283 [Abstract] [Full Text] [Related]
22. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner. Peter K, Gupta A, Nordt T, Bauer S, Runge MS, Bode C. J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328 [Abstract] [Full Text] [Related]
23. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene. Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL. Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425 [Abstract] [Full Text] [Related]
24. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J. J Clin Invest; 1990 Aug 01; 86(2):385-91. PubMed ID: 2384594 [Abstract] [Full Text] [Related]
25. Bivalirudin: a new promising direct antithrombin. Bhambhani A, Meier B. Indian Heart J; 2007 Aug 01; 59(3):288-94. PubMed ID: 19124943 [Abstract] [Full Text] [Related]
26. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma. Baier K, Cvirn G, Fritsch P, Köstenberger M, Gallistl S, Leschnik B, Muntean W. Pediatr Res; 2005 May 01; 57(5 Pt 1):685-9. PubMed ID: 15718352 [Abstract] [Full Text] [Related]
27. Fibrinogen inhibits the heparin cofactor II-mediated antithrombin activity of dermatan sulfate. Zammit A, Dawes J. Blood; 1995 Feb 01; 85(3):720-6. PubMed ID: 7833476 [Abstract] [Full Text] [Related]
28. Characterization of the anticoagulant actions of a semisynthetic curdlan sulfate. Alban S, Franz G. Thromb Res; 2000 Aug 15; 99(4):377-88. PubMed ID: 10963788 [Abstract] [Full Text] [Related]
29. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells. Kaji T, Itoh F, Hayakawa Y, Oguma Y, Sakuragawa N. Thromb Res; 1989 Oct 01; 56(1):99-107. PubMed ID: 2512688 [Abstract] [Full Text] [Related]
30. Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro. Buchanan MR, Maclean GA, Brister SJ. Thromb Haemost; 2001 Sep 01; 86(3):909-13. PubMed ID: 11583326 [Abstract] [Full Text] [Related]